Tumour volume measurements over 4 weeks revealed that RNF39 silencing significantly suppressed tumour growth, while co‐silencing of RINT1 with RNF39 restored tumorigenic potential (Figure 9I). This evidence concerns the gene RNF39 and neoplasm.